Insiders / Mazur Leonard L
Mazur Leonard L
CIK 1463414personinsider
Companies
3
First seen
Jul 26, 2021
Last activity
Dec 22, 2025
Companies
| Company | Shares held | Latest |
|---|---|---|
| Citius Oncology, Inc. · CTOR | 1,700,000 | — |
| Citius Pharmaceuticals, Inc. · CTXR | 410,214 | — |
| Tharimmune, Inc. · CNTN | 123,733 | — |
All securities held
7 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Citius Oncology, Inc. | Common stock | 1,700,000 |
| Citius Pharmaceuticals, Inc. | Common stock | 410,214 |
| Tharimmune, Inc. | Common stock | 123,733 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Citius Oncology, Inc. | Options | 3,700,000 |
| Citius Pharmaceuticals, Inc. | Warrants | 89,388 |
| Citius Pharmaceuticals, Inc. | Options | 1,600 |
| Tharimmune, Inc. | Options | 27,353 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 14, 2022 | Other Derivative conversion | CNTN Tharimmune, Inc. Common Stock | $315.9K | +99K | 98,733 0.14% of shares | low |
| Jan 14, 2022 | Buy Open-market buy | CNTN Tharimmune, Inc. Common Stock | $100.0K | +25K +25.32% | 123,733 0.18% of shares | medium |
| Sep 19, 2025 | Grant Grant or award | CTOR Citius Oncology, Inc. Common Stock | $0 |